|1.||Xu, Qiang: 2 articles (01/2010 - 11/2008)|
|2.||Sun, Yang: 2 articles (01/2010 - 11/2008)|
|3.||Yin, Ye: 2 articles (01/2010 - 11/2008)|
|4.||Wu, Xing-Xin: 1 article (01/2010)|
|5.||Shen, Yan: 1 article (01/2010)|
|6.||Wu, Xue-Feng: 1 article (01/2010)|
|7.||Zhou, Xiao-Bin: 1 article (01/2010)|
|8.||Cai, Tian-Tian: 1 article (01/2010)|
|9.||Gong, Fang-Yuan: 1 article (01/2010)|
|10.||Sheng, Xia: 1 article (11/2008)|
11/01/2008 - "In this study, we aimed at examining the anti-proliferative activity of cirsilineol against multiple types of cancer cells and the underlying mechanisms. "
11/01/2008 - "These results suggested that the induction of apoptosis via the mitochondrial pathway was involved in the anti-proliferative activity of cirsilineol against cancer cells."
11/01/2008 - "Cirsilineol inhibits proliferation of cancer cells by inducing apoptosis via mitochondrial pathway."
01/15/2010 - "In the present study, we found that cirsilineol, a small natural compound isolated from Artemisia vestita, significantly ameliorated trinitro-benzene sulfonic acid (TNBS)-induced T-cell-mediated experimental colitis in mice, which was closely associated with reduced autoreactive T-cell proliferation and activation. "
|3.||Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/15/2010 - "These results strongly suggest that cirsilineol might be potentially useful for treating T-cell-mediated human inflammatory bowel diseases."
01/15/2010 - "Novel immunomodulatory properties of cirsilineol through selective inhibition of IFN-gamma signaling in a murine model of inflammatory bowel disease."